314 related articles for article (PubMed ID: 9973020)
1. A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation.
Stevens MA; McCullough PA; Tobin KJ; Speck JP; Westveer DC; Guido-Allen DA; Timmis GC; O'Neill WW
J Am Coll Cardiol; 1999 Feb; 33(2):403-11. PubMed ID: 9973020
[TBL] [Abstract][Full Text] [Related]
2. Forced euvolemic diuresis with mannitol and furosemide for prevention of contrast-induced nephropathy in patients with CKD undergoing coronary angiography: a randomized controlled trial.
Majumdar SR; Kjellstrand CM; Tymchak WJ; Hervas-Malo M; Taylor DA; Teo KK
Am J Kidney Dis; 2009 Oct; 54(4):602-9. PubMed ID: 19535188
[TBL] [Abstract][Full Text] [Related]
3. Determinants of serum creatinine trajectory in acute contrast nephropathy.
Guitterez NV; Diaz A; Timmis GC; O'Neill WW; Stevens MA; Sandberg KR; McCullough PA
J Interv Cardiol; 2002 Oct; 15(5):349-54. PubMed ID: 12440177
[TBL] [Abstract][Full Text] [Related]
4. Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial.
Marenzi G; Ferrari C; Marana I; Assanelli E; De Metrio M; Teruzzi G; Veglia F; Fabbiocchi F; Montorsi P; Bartorelli AL
JACC Cardiovasc Interv; 2012 Jan; 5(1):90-7. PubMed ID: 22230154
[TBL] [Abstract][Full Text] [Related]
5. A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients.
Dussol B; Morange S; Loundoun A; Auquier P; Berland Y
Nephrol Dial Transplant; 2006 Aug; 21(8):2120-6. PubMed ID: 16611682
[TBL] [Abstract][Full Text] [Related]
6. Mannitol, furosemide, and dopamine infusion in postoperative renal failure complicating cardiac surgery.
Sirivella S; Gielchinsky I; Parsonnet V
Ann Thorac Surg; 2000 Feb; 69(2):501-6. PubMed ID: 10735688
[TBL] [Abstract][Full Text] [Related]
7. Prevention of postcontrast acute kidney injury after percutaneous transluminal angioplasty by inducing RenalGuard controlled furosemide forced diuresis with matched hydration: study protocol for a randomised controlled trial.
Bolt LJJ; Sigterman TA; Krasznai AG; Sikkink CJM; Schurink GH; Bouwman LH
BMJ Open; 2018 Oct; 8(9):e021842. PubMed ID: 30287607
[TBL] [Abstract][Full Text] [Related]
8. A randomized controlled trial comparing hydration therapy to additional hemodialysis or N-acetylcysteine for the prevention of contrast medium-induced nephropathy: the Dialysis-versus-Diuresis (DVD) Trial.
Reinecke H; Fobker M; Wellmann J; Becke B; Fleiter J; Heitmeyer C; Breithardt G; Hense HW; Schaefer RM
Clin Res Cardiol; 2007 Mar; 96(3):130-9. PubMed ID: 17180572
[TBL] [Abstract][Full Text] [Related]
9. Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents.
Solomon R; Werner C; Mann D; D'Elia J; Silva P
N Engl J Med; 1994 Nov; 331(21):1416-20. PubMed ID: 7969280
[TBL] [Abstract][Full Text] [Related]
10. Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial.
Stone GW; McCullough PA; Tumlin JA; Lepor NE; Madyoon H; Murray P; Wang A; Chu AA; Schaer GL; Stevens M; Wilensky RL; O'Neill WW;
JAMA; 2003 Nov; 290(17):2284-91. PubMed ID: 14600187
[TBL] [Abstract][Full Text] [Related]
11. Mannitol and dopamine in patients undergoing cardiopulmonary bypass: a randomized clinical trial.
Carcoana OV; Mathew JP; Davis E; Byrne DW; Hayslett JP; Hines RL; Garwood S
Anesth Analg; 2003 Nov; 97(5):1222-1229. PubMed ID: 14570627
[TBL] [Abstract][Full Text] [Related]
12. Randomized Evaluation of Heart Failure With Preserved Ejection Fraction Patients With Acute Heart Failure and Dopamine: The ROPA-DOP Trial.
Sharma K; Vaishnav J; Kalathiya R; Hu JR; Miller J; Shah N; Hill T; Sharp M; Tsao A; Alexander KM; Gupta R; Montemayor K; Kovell L; Chasler JE; Lee YJ; Fine DM; Kass DA; Weiss RG; Thiemann DR; Ndumele CE; Schulman SP; Russell SD;
JACC Heart Fail; 2018 Oct; 6(10):859-870. PubMed ID: 30098962
[TBL] [Abstract][Full Text] [Related]
13. Predictors for contrast media-induced nephropathy and long-term survival: prospectively assessed data from the randomized controlled Dialysis-Versus-Diuresis (DVD) trial.
Hölscher B; Heitmeyer C; Fobker M; Breithardt G; Schaefer RM; Reinecke H
Can J Cardiol; 2008 Nov; 24(11):845-50. PubMed ID: 18987758
[TBL] [Abstract][Full Text] [Related]
14. Prevention of radiocontrast medium-induced nephropathy using short-term high-dose simvastatin in patients with renal insufficiency undergoing coronary angiography (PROMISS) trial--a randomized controlled study.
Jo SH; Koo BK; Park JS; Kang HJ; Cho YS; Kim YJ; Youn TJ; Chung WY; Chae IH; Choi DJ; Sohn DW; Oh BH; Park YB; Choi YS; Kim HS
Am Heart J; 2008 Mar; 155(3):499.e1-8. PubMed ID: 18294484
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of high dose versus low dose furosemide with or without dopamine infusion: the Dopamine in Acute Decompensated Heart Failure II (DAD-HF II) trial.
Triposkiadis FK; Butler J; Karayannis G; Starling RC; Filippatos G; Wolski K; Parissis J; Parisis C; Rovithis D; Koutrakis K; Skoularigis J; Antoniou CK; Chrysohoou C; Pitsavos C; Stefanadis C; Nastas J; Tsaknakis T; Mantziari L; Giannakoulas G; Karvounis H; Kalogeropoulos AP; Giamouzis G
Int J Cardiol; 2014 Mar; 172(1):115-21. PubMed ID: 24485633
[TBL] [Abstract][Full Text] [Related]
16. Acute Kidney Injury With the RenalGuard System in Patients Undergoing Transcatheter Aortic Valve Replacement: The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation).
Barbanti M; Gulino S; Capranzano P; Immè S; Sgroi C; Tamburino C; Ohno Y; Attizzani GF; Patanè M; Sicuso R; Pilato G; Di Landro A; Todaro D; Di Simone E; Picci A; Giannetto G; Costa G; Deste W; Giannazzo D; Grasso C; Capodanno D; Tamburino C
JACC Cardiovasc Interv; 2015 Oct; 8(12):1595-604. PubMed ID: 26386766
[TBL] [Abstract][Full Text] [Related]
17. Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty--contrast-induced nephropathy] trial.
Patti G; Ricottini E; Nusca A; Colonna G; Pasceri V; D'Ambrosio A; Montinaro A; Di Sciascio G
Am J Cardiol; 2011 Jul; 108(1):1-7. PubMed ID: 21529740
[TBL] [Abstract][Full Text] [Related]
18. Comparison of oral and intravenous hydration strategies for the prevention of contrast-induced nephropathy in patients undergoing coronary angiography or angioplasty: a randomized clinical trial.
Kong DG; Hou YF; Ma LL; Yao DK; Wang LX
Acta Cardiol; 2012 Oct; 67(5):565-9. PubMed ID: 23252007
[TBL] [Abstract][Full Text] [Related]
19. Furosemide versus mannitol in Japanese patients with thoracic malignancy who received cisplatin-based chemotherapy using short hydration: study protocol for a randomised controlled trial.
Murakami E; Akamatsu H; Shimokawa T; Wada K; Yamamoto N
BMJ Open; 2019 Dec; 9(12):e029057. PubMed ID: 31831529
[TBL] [Abstract][Full Text] [Related]
20. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography.
Manske CL; Sprafka JM; Strony JT; Wang Y
Am J Med; 1990 Nov; 89(5):615-20. PubMed ID: 2239981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
